Expression of Bcl-x in erythroid precursors from patients with polycythemia vera

New England Journal of Medicine

Volumn 338, Issue 9, 1998, Pages 564-571

  Silva, Maite ^a   Richard, Carlos ^a   Benito, Adalberto ^a   Sanz, Cristina ^a   Olalla, Ignacio ^a   Fernández Luna, José Luis ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPHORIN A;

ADULT; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; ERYTHROID CELL; FEMALE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BCL-X PROTEIN; CASE-CONTROL STUDIES; CELL SURVIVAL; CHILD; ERYTHROID PROGENITOR CELLS; ERYTHROPOIETIN; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; POLYCYTHEMIA VERA; PROTO-ONCOGENE PROTEINS C-BCL-2; REFERENCE VALUES; THROMBOCYTOSIS;

EID: 0032568003     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199802263380902     Document Type: Article

References (28)

1. Koeffler HP, Goldwasser E. Erythropoietin radioimmunoassay in evaluating patients with polycythemia. Ann Intern Med 1981;94:44-7.
2. Cotes PM, Doré CJ, Yin JAL, et al. Determination of serum immunoreactive erythropoietin in the investigation of'erythrocytosis. N Engl J Med 1986;315:283-7.
3. Fisher MJ, Prchal JF, Prchal JT, D'Andrea AD. Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera. Blood 1994;84:1982-91.
4. Koury MJ, Bondurant MC. Maintenance by erythropoietin of viability and maturation of murine erythroid precursor cells. J Cell Physiol 1988; 137:65-74.
5. Idem. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990;248:378-81.
6. Kelley LL, Koury MJ, Bondurant MC, Koury ST, Sawyer ST, Wickrema A. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood 1993;82:2340-52.
7. Boise LH, Gonzalez-Garcia M, Postema CE, et al. Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597 608.
8. Benito A, Grillot D, Nuñez G, Fernandez-Luna JL. Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 pro-myelocytic cells. Am J Pathol 1995;146:481-90.
9. L. Blood 1996;87:3837-43.
10. L and Bcl-2. Blood 1996;88:1576-82.
11. Hoffman R, Boswell HS. Polycythemia vera. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, eds. Hematology: basic principles and practice. 2nd ed. New York: Churchill Livingstone, 1995:1121-41.
12. Hoffman R, Silverstein LE, Hromas R Primary thrombocythemia. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, eds. Hematology: basic principles and practice. 2nd ed. New York: Churchill Livingstone, 1995:1174-83,
13. Hughes TP, Goldman JM. Chronic myeloid leukemia. In: Hoffman R, Benz EJ Jr, Shartil SJ, Furie B, Cohen HJ, Silherstein LE, eds. Hematology: basic principles and practice. 2nd ed. New York: Churchill Livingstone, 1995:1142-59.
14. Sanz C, Benito A, Silva M, et al. The expression of Bcl-x is downregulated during differentiation of human hematopoietic progenitor cells along the granulocyte but not the monocyte/macrophage lineage. Blood 1997;89:3199-204.
15. Tepperman AD, Curtis JE, McCulloch EA. Erythropoietic colonies in cultures of human marrow. Blood 1974;44:659-69.
16. Prchal JF, Axelrad AA. Bone-marrow responses in polycythemia vera. N Engl J Med 1974;290:1382.
17. Greenberg BR, Golde DW. Erythropoiesis in familial erythrocytosis. N Engl J Med 1977;296:1080-4.
18. Lemoine F, Najman A, Baillou C, et al. A prospective study of the value of bone marrow erythroid progenitor cultures in polycythemia. Blood 1986;68:996-1002.
19. Krantz SB. Erythropoietin. Blood 1991;77:419-34.
20. Yarbro JW. Mechanism of action of hydroxyurea. Semin Oncol 1992; 19:Suppl 9:1-10.
21. Berlin NI. Diagnosis and classification of the polycythemias. Semin Hematol 1975;12:339-51.
22. Eridani S, Batten E, Sawyer B. Erythroid colony formation in primary thrombocythaemia: evidence of hypersensitivity to erythropoietin. Br J Hacmatol 1984;56:157-61.
23. Sokol L, Prchal JF, Prchal JT. Primary familial and congenital polycythaemia. Lancet 1993;342:115-6.
24. Hess G, Rose P, Gamm H, Papadileris S, Huber C, Seliger B. Molecular analysis of the erythropoietin receptor system in patients with polycythaemia vera. Br J Haematol 1994;88:794-802.
25. Mirza AM, Ezzat S, Axelrad AA. Insulin-like growth factor binding protein-1 is elevated in patients with polycythemia vera and stimulates erythroid burst formation in vitro. Blood 1997;89:1862-9.
26. Correa PN, Eskinazi D, Axelrad AA. Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor1 in vitro: studies in an improved serum-free medium. Blood 1994;83: 99 112.
27. Muta K, Krantz SB. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin like growth factor I as well as erythropoietin. J Cell Physiol 1993;156:264-71.
28. Liu Q, Schacher D, Hurth C, Freund GG, Dantzer R, Kelley KW. Activation of phosphatidylinositol 3′-kinase by insulin-like growth factor-I rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes. J Immunol 1997;159:829-37.